Blood Cancer United
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Blood Cancer United sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Blood Cancer United: 4 sponsored US clinical trials, 2 recruiting.
Blood Cancer United sponsors 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Blood Cancer, with 1 trials.
Upper-quartile sponsor footprint
Blood Cancer United sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
The Impact of CAR-T Cell Therapy on Fertility; A Patient Survey
NCT07173322
The Leukemia and Lymphoma Society (LLS) National Research Registry
NCT04806295
Expressive Writing Program Among Young Adults With Blood Cancer
NCT07413991
The Lymphoma and Leukemia Society Amended COVID-19 Registry
NCT04794387
Therapeutic Areas
What is open in the Blood Cancer United pipeline
2 recruiting of 4 indexed (50% open); 1 completed (25%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Blood Cancer (1 trial), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Blood Cancer United: open-pipeline peers nationwide
Peers matched on 4 registered trials and 50% open enrollment, not the therapeutic-area sidebar.
Blood Cancer United sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 50% open enrollment (± trial volume)
- 1200 Pharma · 50% recruiting · 2 trials
- 1ST Biotherapeutics · 50% recruiting · 2 trials
- 3ive Labs · 50% recruiting · 2 trials
- 7 Hills Pharma · 50% recruiting · 2 trials
Related
What to do with this Blood Cancer United page
4 registered trials is a research-attention snapshot, not an endorsement of Blood Cancer United or any single study.
- 2 of Blood Cancer United's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Blood Cancer is the condition Blood Cancer United studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Blood Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Blood Cancer United pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.